Compare Johnson & Johnson (JNJ) vs Realty Income Corp (O) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Realty Income Corp — how do they compare? Johnson & Johnson trades at $260.1 (market cap $626.09B), while Realty Income Corp trades at $62.56 (market cap $58.56B). The key difference: Johnson & Johnson is far larger — about 10.7× Realty Income Corp's market cap, and Realty Income Corp pays the higher dividend (5.25%). Which is the better fit depends on your goals.
| JNJ | O | |
|---|---|---|
Market Cap | $626.09B | $58.56B |
Volume | 6,156,228 | — |
Sector | Health | Real Estate |
52-Week High | $267.24 | $67.56 |
52-Week Low | $172.78 | $55.93 |
Enterprise Value | $654.37B | $89.19B |
Dividend Yield | 2.06% | 5.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.
Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.
Realty Income (O) trades at $62.43, up 0.87% with a bearish technical signal despite bullish oscillators. The REIT reported three consecutive quarterly EPS misses but maintains strong fundamentals with 92.56% gross margins and 21.23% net income margin. Recent news highlights a $875 million convertible notes offering and the company's 115th consecutive dividend increase, supporting its monthly dividend reputation. Revenue growth continues from $5.3B in 2024 to $5.7B in 2025, though debt-to-asset ratio has risen to 39.93%.
The stock presents a mixed outlook with analyst consensus at Buy (41%) and $67.29 price target offering 7.8% upside. Key opportunities include reliable dividends and portfolio expansion into data centers, while risks involve rising leverage and interest rate sensitivity. Technical resistance at $62-63 levels may cap near-term gains despite oversold RSI conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Realty Income Corp
Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.
Read more on O →
